Fluorine in PDB 3ij8: Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Enzymatic activity of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
All present enzymatic activity of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase:
3.2.1.1;
Protein crystallography data
The structure of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase, PDB code: 3ij8
was solved by
C.Li,
R.Zhang,
S.G.Withers,
G.D.Brayer,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.33 /
1.43
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
52.000,
68.470,
129.860,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.7 /
21.3
|
Other elements in 3ij8:
The structure of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
(pdb code 3ij8). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 7 binding sites of Fluorine where determined in the
Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase, PDB code: 3ij8:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
Fluorine binding site 1 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 1 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:26.5
occ:1.00
|
F1
|
A:B0D501
|
0.0
|
26.5
|
1.0
|
CX1
|
A:B0D501
|
1.4
|
27.8
|
1.0
|
OX5
|
A:B0D501
|
2.3
|
28.0
|
1.0
|
CX2
|
A:B0D501
|
2.4
|
27.0
|
1.0
|
CX6
|
A:B0D501
|
2.8
|
29.4
|
1.0
|
OX2
|
A:B0D501
|
2.8
|
26.5
|
1.0
|
CX5
|
A:B0D501
|
3.0
|
28.6
|
1.0
|
CX3
|
A:B0D501
|
3.0
|
27.6
|
1.0
|
O
|
A:HOH733
|
3.2
|
27.7
|
1.0
|
OX6
|
A:B0D501
|
3.2
|
30.1
|
1.0
|
O
|
A:HOH755
|
3.3
|
41.1
|
1.0
|
CD1
|
A:ILE235
|
3.4
|
22.1
|
1.0
|
CX4
|
A:B0D501
|
3.6
|
27.4
|
1.0
|
F2
|
A:B0D501
|
4.2
|
29.2
|
1.0
|
OX3
|
A:B0D501
|
4.3
|
27.0
|
1.0
|
OX4
|
A:B0D501
|
4.6
|
27.4
|
1.0
|
O
|
A:HOH645
|
4.6
|
24.7
|
1.0
|
CG1
|
A:ILE235
|
4.7
|
21.6
|
1.0
|
CB
|
A:ILE235
|
4.9
|
20.7
|
1.0
|
|
Fluorine binding site 2 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 2 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:29.2
occ:1.00
|
F2
|
A:B0D501
|
0.0
|
29.2
|
1.0
|
CX5
|
A:B0D501
|
1.4
|
28.6
|
1.0
|
CX6
|
A:B0D501
|
2.3
|
29.4
|
1.0
|
OX5
|
A:B0D501
|
2.3
|
28.0
|
1.0
|
CX4
|
A:B0D501
|
2.4
|
27.4
|
1.0
|
O6
|
A:B9D504
|
2.7
|
36.5
|
1.0
|
OX6
|
A:B0D501
|
2.7
|
30.1
|
1.0
|
OX4
|
A:B0D501
|
2.9
|
27.4
|
1.0
|
O
|
A:HOH742
|
3.1
|
46.1
|
1.0
|
CX1
|
A:B0D501
|
3.7
|
27.8
|
1.0
|
O4
|
A:B9D504
|
3.7
|
35.5
|
1.0
|
C3
|
A:B9D504
|
3.7
|
33.5
|
1.0
|
CX3
|
A:B0D501
|
3.8
|
27.6
|
1.0
|
OD2
|
A:ASP300
|
4.0
|
22.8
|
1.0
|
C6
|
A:B9D504
|
4.0
|
34.5
|
1.0
|
O
|
A:HIS305
|
4.0
|
42.2
|
1.0
|
O3
|
A:B9D504
|
4.1
|
31.6
|
1.0
|
CX2
|
A:B0D501
|
4.2
|
27.0
|
1.0
|
F1
|
A:B0D501
|
4.2
|
26.5
|
1.0
|
OD1
|
A:ASP300
|
4.2
|
23.4
|
1.0
|
CG
|
A:ASP300
|
4.3
|
20.8
|
1.0
|
C4
|
A:B9D504
|
4.3
|
34.1
|
1.0
|
C5
|
A:B9D504
|
4.8
|
33.8
|
1.0
|
OX3
|
A:B0D501
|
4.9
|
27.0
|
1.0
|
C2
|
A:B9D504
|
4.9
|
33.1
|
1.0
|
|
Fluorine binding site 3 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 3 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:38.0
occ:1.00
|
F1
|
A:B0D502
|
0.0
|
38.0
|
1.0
|
CX1
|
A:B0D502
|
1.4
|
38.2
|
1.0
|
OX5
|
A:B0D502
|
2.4
|
38.0
|
1.0
|
CX2
|
A:B0D502
|
2.5
|
38.4
|
1.0
|
OX2
|
A:B0D502
|
2.8
|
38.1
|
1.0
|
CX6
|
A:B0D502
|
2.9
|
38.7
|
1.0
|
OX6
|
A:B0D502
|
3.0
|
39.8
|
1.0
|
CX5
|
A:B0D502
|
3.1
|
38.4
|
1.0
|
CX3
|
A:B0D502
|
3.1
|
38.3
|
1.0
|
CX4
|
A:B0D502
|
3.7
|
38.2
|
1.0
|
F2
|
A:B0D502
|
4.3
|
37.8
|
1.0
|
OX3
|
A:B0D502
|
4.4
|
40.1
|
1.0
|
CE3
|
A:TRP203
|
4.6
|
17.0
|
1.0
|
CZ3
|
A:TRP203
|
4.7
|
18.4
|
1.0
|
CD2
|
A:TRP203
|
4.7
|
16.6
|
1.0
|
OX4
|
A:B0D502
|
4.8
|
37.8
|
1.0
|
O
|
A:HOH546
|
4.9
|
19.8
|
1.0
|
|
Fluorine binding site 4 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 4 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:37.8
occ:1.00
|
F2
|
A:B0D502
|
0.0
|
37.8
|
1.0
|
CX5
|
A:B0D502
|
1.4
|
38.4
|
1.0
|
CX6
|
A:B0D502
|
2.3
|
38.7
|
1.0
|
OX5
|
A:B0D502
|
2.3
|
38.0
|
1.0
|
CX4
|
A:B0D502
|
2.4
|
38.2
|
1.0
|
OX6
|
A:B0D502
|
2.8
|
39.8
|
1.0
|
OX4
|
A:B0D502
|
2.9
|
37.8
|
1.0
|
O
|
A:HOH546
|
3.2
|
19.8
|
1.0
|
N
|
A:ASP206
|
3.4
|
13.1
|
1.0
|
CA
|
A:GLY205
|
3.4
|
13.7
|
1.0
|
CB
|
A:TRP203
|
3.5
|
14.5
|
1.0
|
OD1
|
A:ASP206
|
3.5
|
16.5
|
1.0
|
C
|
A:GLY205
|
3.6
|
13.0
|
1.0
|
CX1
|
A:B0D502
|
3.7
|
38.2
|
1.0
|
N
|
A:GLY205
|
3.7
|
13.7
|
1.0
|
CX3
|
A:B0D502
|
3.8
|
38.3
|
1.0
|
CG
|
A:ASP206
|
3.9
|
15.1
|
1.0
|
CG
|
A:TRP203
|
4.1
|
14.9
|
1.0
|
CX2
|
A:B0D502
|
4.2
|
38.4
|
1.0
|
F1
|
A:B0D502
|
4.3
|
38.0
|
1.0
|
CA
|
A:ASP206
|
4.3
|
13.6
|
1.0
|
OD2
|
A:ASP206
|
4.3
|
15.6
|
1.0
|
CB
|
A:ASP206
|
4.5
|
14.3
|
1.0
|
O
|
A:GLY205
|
4.5
|
14.0
|
1.0
|
C
|
A:TRP203
|
4.7
|
13.7
|
1.0
|
O
|
A:HOH860
|
4.7
|
49.4
|
1.0
|
CA
|
A:TRP203
|
4.7
|
14.0
|
1.0
|
CD2
|
A:TRP203
|
4.8
|
16.6
|
1.0
|
O
|
A:TRP203
|
4.8
|
13.7
|
1.0
|
CD1
|
A:TRP203
|
4.8
|
15.4
|
1.0
|
OX3
|
A:B0D502
|
4.9
|
40.1
|
1.0
|
C
|
A:PRO204
|
5.0
|
13.1
|
1.0
|
|
Fluorine binding site 5 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 5 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:18.0
occ:1.00
|
F1
|
A:B0D503
|
0.0
|
18.0
|
1.0
|
CX1
|
A:B0D503
|
1.4
|
19.5
|
1.0
|
OX5
|
A:B0D503
|
2.3
|
19.2
|
1.0
|
CX2
|
A:B0D503
|
2.4
|
19.9
|
1.0
|
OX2
|
A:B0D503
|
2.8
|
20.9
|
1.0
|
CX6
|
A:B0D503
|
2.8
|
19.1
|
1.0
|
CX3
|
A:B0D503
|
3.0
|
20.7
|
1.0
|
CX5
|
A:B0D503
|
3.0
|
20.2
|
1.0
|
OX6
|
A:B0D503
|
3.2
|
17.0
|
1.0
|
CX4
|
A:B0D503
|
3.6
|
20.5
|
1.0
|
CD
|
A:LYS208
|
3.6
|
22.2
|
1.0
|
O
|
A:GLY249
|
3.7
|
14.1
|
1.0
|
CA
|
A:GLY249
|
3.7
|
11.7
|
1.0
|
C
|
A:GLY249
|
3.9
|
11.9
|
1.0
|
F2
|
A:B0D503
|
4.2
|
21.2
|
1.0
|
OX3
|
A:B0D503
|
4.3
|
22.3
|
1.0
|
CG
|
A:LYS208
|
4.3
|
18.2
|
1.0
|
O
|
A:HOH532
|
4.5
|
14.9
|
1.0
|
OD1
|
A:ASN250
|
4.6
|
14.4
|
1.0
|
OX4
|
A:B0D503
|
4.6
|
22.1
|
1.0
|
NZ
|
A:LYS208
|
4.8
|
22.7
|
1.0
|
N
|
A:GLY249
|
4.8
|
11.6
|
1.0
|
CE
|
A:LYS208
|
4.8
|
24.0
|
1.0
|
N
|
A:ASN250
|
5.0
|
12.7
|
1.0
|
CB
|
A:LYS208
|
5.0
|
14.2
|
1.0
|
|
Fluorine binding site 6 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 6 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:21.2
occ:1.00
|
F2
|
A:B0D503
|
0.0
|
21.2
|
1.0
|
CX5
|
A:B0D503
|
1.4
|
20.2
|
1.0
|
CX6
|
A:B0D503
|
2.3
|
19.1
|
1.0
|
OX5
|
A:B0D503
|
2.3
|
19.2
|
1.0
|
CX4
|
A:B0D503
|
2.4
|
20.5
|
1.0
|
OX6
|
A:B0D503
|
2.7
|
17.0
|
1.0
|
OX4
|
A:B0D503
|
2.9
|
22.1
|
1.0
|
O
|
A:HOH532
|
3.2
|
14.9
|
1.0
|
CB
|
A:PRO204
|
3.6
|
13.8
|
1.0
|
CX1
|
A:B0D503
|
3.7
|
19.5
|
1.0
|
CX3
|
A:B0D503
|
3.7
|
20.7
|
1.0
|
O
|
A:HOH860
|
4.1
|
49.4
|
1.0
|
O
|
A:ASP246
|
4.1
|
12.9
|
1.0
|
CX2
|
A:B0D503
|
4.2
|
19.9
|
1.0
|
F1
|
A:B0D503
|
4.2
|
18.0
|
1.0
|
C
|
A:PRO204
|
4.4
|
13.1
|
1.0
|
N
|
A:GLY205
|
4.5
|
13.7
|
1.0
|
CA
|
A:PRO204
|
4.6
|
13.0
|
1.0
|
CG
|
A:PRO204
|
4.7
|
13.2
|
1.0
|
O
|
A:PRO204
|
4.7
|
12.8
|
1.0
|
OX3
|
A:B0D503
|
4.8
|
22.3
|
1.0
|
CA
|
A:GLY205
|
5.0
|
13.7
|
1.0
|
|
Fluorine binding site 7 out
of 7 in 3ij8
Go back to
Fluorine Binding Sites List in 3ij8
Fluorine binding site 7 out
of 7 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F504
b:35.0
occ:1.00
|
F1
|
A:B9D504
|
0.0
|
35.0
|
1.0
|
C5
|
A:B9D504
|
1.4
|
33.8
|
1.0
|
O
|
A:B9D504
|
2.3
|
33.3
|
1.0
|
C6
|
A:B9D504
|
2.4
|
34.5
|
1.0
|
C4
|
A:B9D504
|
2.4
|
34.1
|
1.0
|
O4
|
A:B9D504
|
2.9
|
35.5
|
1.0
|
CB
|
A:TYR62
|
2.9
|
13.3
|
1.0
|
O
|
A:TYR62
|
3.4
|
14.4
|
1.0
|
NE2
|
A:HIS101
|
3.4
|
14.0
|
1.0
|
O6
|
A:B9D504
|
3.5
|
36.5
|
1.0
|
C1
|
A:B9D504
|
3.6
|
32.8
|
1.0
|
C3
|
A:B9D504
|
3.7
|
33.5
|
1.0
|
CE1
|
A:HIS101
|
3.7
|
13.6
|
1.0
|
CG
|
A:TYR62
|
3.8
|
12.2
|
1.0
|
CD2
|
A:LEU165
|
3.8
|
18.1
|
1.0
|
CA
|
A:TYR62
|
4.0
|
13.7
|
1.0
|
C
|
A:TYR62
|
4.1
|
14.2
|
1.0
|
C2
|
A:B9D504
|
4.1
|
33.1
|
1.0
|
CD1
|
A:TYR62
|
4.2
|
13.8
|
1.0
|
O
|
A:HOH675
|
4.3
|
31.6
|
1.0
|
OD2
|
A:ASP197
|
4.5
|
18.1
|
1.0
|
CD2
|
A:HIS101
|
4.6
|
13.8
|
1.0
|
OD1
|
A:ASP197
|
4.7
|
16.2
|
1.0
|
CD2
|
A:TYR62
|
4.7
|
13.3
|
1.0
|
O3
|
A:B9D504
|
4.8
|
31.6
|
1.0
|
ND1
|
A:HIS101
|
4.9
|
13.4
|
1.0
|
CG
|
A:ASP197
|
5.0
|
14.6
|
1.0
|
|
Reference:
R.Zhang,
C.Li,
L.K.Williams,
B.P.Rempel,
G.D.Brayer,
S.G.Withers.
Directed "in Situ" Inhibitor Elongation As A Strategy to Structurally Characterize the Covalent Glycosyl-Enzyme Intermediate of Human Pancreatic Alpha-Amylase Biochemistry V. 48 10752 2009.
ISSN: ISSN 0006-2960
PubMed: 19803533
DOI: 10.1021/BI901400P
Page generated: Wed Jul 31 19:31:53 2024
|